These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24856594)

  • 1. Managing heterogeneity in prescription drug coverage policies.
    Teagarden JR
    J Manag Care Spec Pharm; 2014 Jun; 20(6):564-5. PubMed ID: 24856594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an educational program on deciphering heterogeneity for medical coverage decisions.
    Warholak TL; Hilgaertner JW; Dean JL; Taylor AM; Hines LE; Hurwitz J; Brown M; Malone DC
    J Manag Care Spec Pharm; 2014 Jun; 20(6):566-73. PubMed ID: 24856595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis.
    Shah ED; Chang L; Lembo A; Staller K; Curley MA; Chey WD
    Dig Dis Sci; 2021 Dec; 66(12):4140-4148. PubMed ID: 33433804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.
    Gaffney A; Lexchin J; ;
    BMJ; 2018 May; 361():k1039. PubMed ID: 29773533
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
    Mendoza RL
    J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 8. How does drug coverage vary by insurance type? Analysis of drug formularies in the United States.
    Régnier SA
    Am J Manag Care; 2014 Apr; 20(4):322-31. PubMed ID: 24884863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensuring fairness in coverage decisions: applying the American Medical Association Ethical Force Program's consensus report to managed care pharmacy.
    Teagarden JR; Wynia MK
    Am J Health Syst Pharm; 2006 Sep; 63(18):1749-54. PubMed ID: 16960260
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical and pharmacy coverage decision making at the population level.
    Mohr PE; Tunis SR
    J Manag Care Spec Pharm; 2014 Jun; 20(6):547-54. PubMed ID: 24856592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surprising ways to cut your drug costs: even with insurance you might be paying too much.
    Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299
    [No Abstract]   [Full Text] [Related]  

  • 12. The Medicare prescription drug proposals and health insurance risk.
    Gencarelli DM
    NHPF Issue Brief; 2003 Sep; (793):1-12. PubMed ID: 12964574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):823-824. PubMed ID: 31711103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.
    McLeod L; Bereza BG; Shim M; Grootendorst P
    Open Med; 2011; 5(1):e1-9. PubMed ID: 22046212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of formulary drug exclusion policies on patients and healthcare costs.
    Chambers JD; Rane PB; Neumann PJ
    Am J Manag Care; 2016 Aug; 22(8):524-31. PubMed ID: 27541699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Medicare prescription drug benefit: focusing on coverage and cost.
    Cubanski J; Kline J
    Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain.
    Urmie JM; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):85-9. PubMed ID: 20511107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.